Drugs / Revaprazan
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03378284 Comparator | Dec 2017 | — | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Revaprazan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03378284 ↗ |
| Route | Oral | “after oral administration” NCT03378284 ↗ |